ACRS icon

Aclaris Therapeutics

95 hedge funds and large institutions have $227M invested in Aclaris Therapeutics in 2019 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 36 increasing their positions, 25 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less funds holding

Funds holding:

less first-time investments, than exits

New positions opened: | Existing positions closed:

21% less capital invested

Capital invested by funds: $289M → $227M (-$61.5M)

76% less call options, than puts

Call options by funds: $68K | Put options by funds: $288K

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
95
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$68K
Puts
$288K
Net Calls
Net Calls Change

Top Sellers

1 -$5.96M
2 -$5.53M
3 -$4.54M
4
UBS Group
UBS Group
Switzerland
-$3.8M
5
BlackRock
BlackRock
New York
-$2.92M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$35.3M
2
$24M
3
$18.8M
4
$12.2M
5
$11.4M
6
$11.1M
7
$11M
8
$10.2M
9
$9.87M
10
$8.98M
11
$7.1M
12
$6.41M
13
$4.49M
14
$4.19M
15
$4.09M
16
$3.92M
17
$3.8M
18
$3.58M
19
$3.27M
20
$2.8M
21
$2.61M
22
$2.56M
23
$2.52M
24
$1.58M
25
$1.47M